4.5 Article

An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN

Journal

HUMAN MOLECULAR GENETICS
Volume 9, Issue 2, Pages 259-266

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/hmg/9.2.259

Keywords

-

Funding

  1. NINDS NIH HHS [R01 NS040275] Funding Source: Medline

Ask authors/readers for more resources

The survival motor neuron genes, SMN1 and SMN2, encode identical proteins; however, only homozygous loss of SMN1 correlates with the development of spinal muscular atrophy (SMA). We have previously shown that a single non-polymorphic nucleotide difference in SMN exon 7 dramatically affects SMN mRNA processing. SMN1 primarily produces a full-length RNA whereas SMN2 expresses dramatically reduced full-length RNA and abundant levels of an aberrantly spliced transcript lacking exon 7, The importance of proper exon 7 processing has been underscored by the identification of several mutations within splice sites adjacent to exon 7, Here we show that an AG-rich exonic splice enhancer (ESE) in the center of SMN exon 7 is required for inclusion of exon 7, This region functioned as an ESE in a heterologous context, supporting efficient in vitro splicing of the Drosophila double-sex gene. Finally, the protein encoded by the exon-skipping event, Delta 7, was less stable than full-length SMN, providing additional evidence of why SMN2 fails to compensate for the loss of SMN1 and leads to the development of SMA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available